Phagemid-based capsid system delivers CRISPR-Cas13a to target MRSA, showing efficient packaging, minimal wild-type phage contamination, and specific bactericidal activity, providing a promising alternative to antibiotics.
- Feng-Yu Li
- Xin-Ee Tan
- Longzhu Cui